According to a new market, the global drugs of abuse testing market was valued at US$ 4.2 Bn in 2016 and is expected to grow at a CAGR of 5.4 % during the forecast period from 2017 to 2025 to reach US$ 6.7 Bn in 2025.
Drug of abuse testing, is also called is drug abuse testing is the process of confirming the presence of drugs in the body of an individual by testing of the individual’s sample like the urine, saliva, blood or hair. Drug of abuse testing is done in order to identify the drugs that an individual has taken and to provide necessary medical treatment against the harmful effects of drugs. Drug abuse testing is also used to identify the illegal drug use. Growing illicit drug consumption and demand for drug testing in the workplace define the market dynamics of the drug of abuse testing testing market.
Based on the product, the market has been further segmented into three major sub segments namely, analyzers, rapid testing devices and consumables. The analyzers product type segment is further sub – segmented into immunoassay analyzers, chromatographic devices and breath analyzers. The rapid testing devices product type segment is further sub segmented into urine testing devices and oral fluid testing devices. The consumables product type segment is further sub – segmented into fluid collection devices and others. Consumables segment emerged as the segment leader in terms of revenue in 2016, attributed to the increasing demand for reagents and sample collection devices required for drug testing. Among the various types of drug abuse testing products, the rapid testing devices segment is likely to record the highest growth rate during the period 2017 – 2025. Owing to the ease of use, rapid results and low price of the rapid test kits the demand for these products is high among end users like the law enforcement agencies.
Based on the sample type, the drug of abuse testing market has been segmented into saliva, breath, urine, blood, hair and sweat. Further with sample type, the urine sample type segment has greater market share from the total drug of abuse testing market in 2016. Such growth has been attributed to the variety of drug tests conducted that can be performed on the urine sample and easy storage methods for urine sample. Various drug tests available in the market work on urine sample owing to which the demand for urine sample testing segment of drugs of abuse testing market is likely to drive the market. Urine sample type segment was observed to be the market leader in 2016. Based on end users, the drug of abuse testing market has been further segmented into hospitals, diagnostics laboratories, on-the-spot testing, forensic laboratories. In terms of end-user, the on the spot testing segment led the market in 2016 due to the increasing number of tests performed by the law enforcement agencies and drug screening centers.
Request Sample of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1746
Geographically, the drugs of abuse testing market has been categorized into five regions: North America, Europe, Asia Pacific, Latin America and Middle East and Africa. In terms of geographic distribution, North America dominated the global drugs of abuse testing market in 2016. The region accounted for a share of over 49.3% of the global drugs of abuse testing market in the same year. Factors such as emerging new product portfolio and expansion of companies were attributed to the high growth in the region. In Europe, Germany and France accounted more than 40% share of the total Europe drugs of abuse testing market in 2016. Asia Pacific was also observed to witness rapid growth in the market. Increasing demand for drug testing from the government agencies is expected to boost the drugs of abuse testing market in the region during the forecast period.
Major players operating in the global drugs of abuse testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Drägerwerk AG & Co. KGaA, Laboratory Corporation of America Holdings, Siemens Healthineers, Abbott Laboratories and Danaher Corporation (Beckman Coulter, Inc.) exhibit the largest geographical outreach with presence in multiple drugs of abuse testing products.